Abstract
HIV chemoprophylaxis (PrEP/PEP) has emerged as a transformative prevention tool to reduce infection rates and decrease disease burden. However, uptake is low, and efficacy depends upon adherence. To maximize impact, potential barriers to uptake and adherence must be identified and understood. Using univariate and logistic regression analytic methods, we assessed associations among potential barriers to uptake and adherence, including HIV chemoprophylaxis knowledge, negative stereotyped beliefs about people who use it and negative attitudes towards HIV chemoprophylaxis use by relatives among 583 residents of two high HIV prevalence neighborhoods in New York City. About a quarter of respondents knew about HIV chemoprophylaxis and over 50 % endorsed negative stereotyped beliefs about users; yet, approximately two-thirds had positive attitudes toward its use among a male or female relative. Young age, having lesbian or gay friends/family members and low levels of homophobia were associated with not endorsing negative stereotyped beliefs. Negative stereotyped beliefs were not associated with negative attitudes toward HIV chemoprophylaxis use among relatives. Implications for PrEP dissemination are discussed.
References
Centers for Disease Control and Prevention. HIV among gay and bisexual men [Slide set]. 2014. http://www.cdc.gov/hiv/pdf/library/slidesets/cdc-hiv-surveillance-genepi.pdf.
New York City Department of Health and Mental Hygeine. New York City HIV/AIDS annual surveillance statistics 2013. 2015. http://www.nyc.gov/html/doh/downloads/pdf/ah/surveillance2013-table-all.pdf.
Cáceres CF, Koechlin F, Goicochea P, Sow P-S, O’Reilly K, Mayer K, et al. The promises and challenges of pre-exposure prophylaxis as part of the emerging paradigm of combination HIV prevention. J Int AIDS Soc. 2015;18(Suppl 3):19949.
US Food and Drug Administration. FDA approves first drug for reducing the risk of sexually acquired HIV infection 2012 [December 27, 2015]. http://www.fda.gov/downloads/ForConsumers/ConsumerUpdates/UCM311828.pdf.
Centers for Disease Control and Prevention. Preexposure prophylaxis for the prevention of HIV infection in the United States–2014: a clinical practice guideline. Atlanta: CDC; 2014.
Dolezal C, Frasca T, Giguere R, Ibitoye M, Cranston RD, Febo I, et al. Awareness of post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP) is low but interest is high among men engaging in condomless anal sex with men in Boston, Pittsburgh, and San Juan. AIDS Educ Prev. 2015;27(4):289–97.
Spinner CD, Boesecke C, Zink A, Jessen H, Stellbrink H-J, Rockstroh JK, et al. HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans. Infection 2016;44(2):151–8.
Haire BG. Preexposure prophylaxis-related stigma: strategies to improve uptake and adherence—a narrative review. HIV/AIDS (Auckland, NZ). 2015;7:241–9.
Calabrese SK, Underhill K. How stigma surrounding the use of HIV preexposure prophylaxis undermines prevention and pleasure: a call to destigmatize “Truvada Whores”. Am J Public Health. 2015;105(10):1960–4.
Genberg BL, Hlavka Z, Konda KA, Maman S, Chariyalertsak S, Chingono A, et al. A comparison of HIV/AIDS-related stigma in four countries: negative attitudes and perceived acts of discrimination towards people living with HIV/AIDS. Soc Sci Med. 2009;68(12):2279–87.
Visser MJ, Makin JD, Vandormael A, Sikkema KJ, Forsyth BW. HIV/AIDS stigma in a South African community. AIDS Care. 2009;21(2):197–206.
Herek GM. AIDS and stigma. Am Behav Sci. 1999;42(7):1106–16.
Morrison MA, Morrison TG. Development and validation of a scale measuring modern prejudice toward gay men and lesbian women. J Homosex. 2002;43(2):15–37.
Mayfield W. The development of an internalized homonegativity inventory for gay men. J Homosex. 2001;41(2):53–76.
Hosmer DW Jr, Lemeshow S, Sturdivant RX. Model-building strategies and methods for logistic regression. Applied logistic regression. 2nd ed. New York: Wiley; 2000. p. 89–151.
Auerbach JD, Kinsky S, Brown G, Charles V. Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV. AIDS Patient Care STDs. 2015;29(2):102–10.
Bauermeister JA, Meanley S, Pingel E, Soler JH, Harper GW. PrEP awareness and perceived barriers among single young men who have sex with men. Curr HIV Res. 2013;11(7):520–7.
Rucinski KB, Mensah NP, Sepkowitz KA, Cutler BH, Sweeney MM, Myers JE. Knowledge and use of pre-exposure prophylaxis among an online sample of young men who have sex with men in New York City. AIDS Behav. 2013;17(6):2180–4.
New York City Department of Health and Mental Hygeine. Health Department Launches New PrEP and PEP Campaign: New Ways to Prevent HIV 2015. http://www.nyc.gov/html/doh/html/pr2015/pr003-15.shtml.
Walch SE, Orlosky PM, Sinkkanen KA, Stevens HR. Demographic and social factors associated with homophobia and fear of AIDS in a community sample. J Homosex. 2010;57(2):310–24.
Katz IT, Ryu AE, Onuegbu AG, Psaros C, Weiser SD, Bangsberg DR, et al. Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. J Int AIDS Soc. 2013;16(3 Suppl 2):18640.
Liu A, Cohen S, Follansbee S, Cohan D, Weber S, Sachdev D, et al. Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Med. 2014;11(3):e1001613.
Acknowledgments
The authors acknowledge the contributions of Vaughn Taylor-Akutagawa, Steven Gordon, David Matthews, Mark Kornegay, Geneva Musgrave and staff and volunteers of Gay Men of African Descent and Bridging Access to Care for their contributions to Project CHHANGE, the parent study. We also thank the study participants who gave their time and effort to this study.
Funding
This study was funded by the National Institute of Mental Health Grant (R21MH102182).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflicts of interest.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed Consent
Verbal informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Farhat, D., Greene, E., Paige, M.Q. et al. Knowledge, Stereotyped Beliefs and Attitudes Around HIV Chemoprophylaxis in Two High HIV Prevalence Neighborhoods in New York City. AIDS Behav 21, 1247–1255 (2017). https://doi.org/10.1007/s10461-016-1426-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-016-1426-6